Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects
Clinical trial NCT01230385 · COMPLETED
Trial details
- NCT number
- NCT01230385
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2011-05-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.